Pfizer Chinese JV partner gets FDA warning letter; AZ teams up with feds on antibiotic development;

@FiercePharma: ViroVet spins out of Aratana with focus on livestock health. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: BMS' Opdivo guns for kidney cancer nod with FDA 'breakthrough' tag. Article | Follow @CarlyHFierce

> The Chinese half of a Pfizer ($PFE) joint venture has found itself crosswise with the FDA, which has banned products from one of its plants. Report

> AstraZeneca ($AZN) signed up with the Department of Health and Human Services to develop antibiotics for use against bioterrorism agents and drug-resistant infections. Report

> A gay man taking Gilead Sciences' ($GILD) Truvada as an HIV-prevention tool says Mutual of Omaha discriminated against him when it turned him down for long-term care insurance. Report

> Hayman Capital's Kyle Bass continues to maintain that his Coalition for Affordable Drugs is only challenging the "worst" drug patents. Report

> Some blood pressure drugs may increase the risk of colorectal polyps, a new study found. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Pentax backs $8M+ round for electrosurgery startup Creo. Article | Follow @FierceMedDev

@EmilyWFierce: Report: Cancer drug spending fuels large increases in Medicare discount drug program. ICYMI from FiercePharma | Follow @EmilyWFierce

> Mobile health apps top 165K mark, with 300 clinical trials using them. More

> Zoll buys an Israeli wearable cardiac monitor maker for $35M. Article

> FDA beefs up testing for duodenoscope cleaning devices. Report

Biotech News

@FierceBiotech: Aerie skyrockets on a mixed success in second PhIII glaucoma study. Article | Follow @FierceBiotech

@JohnCFierce: First on Fierce: OrbiMed sets its sights on a $950M blockbuster biotech fund. News | Follow @JohnCFierce

> A player in J&J's hep C cocktail helps hustle a quick cure. Story

> FDA: Those worries about Addyi and alcohol? We can handle it. More

> Lehmann leaves GSK to head up immuno-oncology at Celyad. Article

Vaccines News

> Takeda joins consortium that accelerates R&D for malaria, TB vaccines. Item

> Vaxent and PREVENT kick off Strep A vaccine trials. More

> Emory team to look at GSK vax response as part of NIH research. Report

> FDA panel recommends Fluad, possibly the first U.S. boosted flu jab. Story

> J&J's Janssen strikes four-year, $28.5M government partnership to advance Ebola vaccine. Article

CRO News

> PRA adding 150 jobs amid Pennsylvania expansion push. Report

> Chiltern closes its Theorem buy, doubling its workforce. Item

> Accelovance inks a nonprofit partnership for melanoma trials. Article

> WuXi brings its genomic heft to Chinese patients with hospital pact. Story

> Evotec upsizes its 2015 projections after a string of partnering deals. Article

Pharma Manufacturing News

> Pfizer Chinese JV partner Zhejiang Hisun Pharma gets FDA warning letter. More

> Nexvet picks up biologics plant in Ireland. Item

> FDA castigates Indian drugmaker over mess at API plant. Report

> Hamburg's pick in line to take over as FDA commissioner. Story

> FDA sears maker of GolfersSkin Sunscreen in warning letter. Article

Pharma Asia News

> Taiwan's TWi Pharmaceuticals raises $87M via GDR in weak pricing. Report

> China's Yabao Pharmaceutical adds to a summer string of tie-ups. Item

> Dual-listed Benitec adds fourth site for hep C trials of TT-034. More

> Low-cost genomic sequencing on the slate for China with Veritas landing? Story

> India's Glenmark says breast cancer candidate GBR 1302 moving to PhI. Article

And Finally... The fake drug industry is exploding, and enforcement is challenging. Report